| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/27/2005 | US20050020808 Biodegradable polyphosphazene polymer with sol-gel behavior; a temperature change in aqueous solution in a temperature near a body temperature |
| 01/27/2005 | US20050020696 Low peak exotherm curable compositions |
| 01/27/2005 | US20050020693 Treating a skin growth with a drying agent before surgical removal or treatment with laser or formaldehyde to form gel or powder |
| 01/27/2005 | US20050020692 Injections for treatment of heaves by breathing or injection through skinfor antiinflammatory agents, tablets, capsules, aerosols of racemic mixtures for treatment in horses |
| 01/27/2005 | US20050020690 Infiltration of capsaicin into surgical sites and open wounds |
| 01/27/2005 | US20050020688 Mixing nimesulfide with vinyl glyceol for topical drug for antiinflammatory agents |
| 01/27/2005 | US20050020674 Comprising [4-[(N,N-diethylcarbamoyl)methoxy]-3-ethoxyphenyl]acetic acid propyl ester, a water-immiscible solvent, an emulsifier, a tonicity modifier, 0.05-0.2% by weight histidine, and water,wherein pH is greater than 7 and wherein composition contains a preservative |
| 01/27/2005 | US20050020671 Core comprises first active ingredient, coating comprising second active ingredient incompatible with first and barrier between core and coating which prevents physical contact between them, characterised in that barrier is formed on core by film-coating and coating is formed by press-coating |
| 01/27/2005 | US20050020658 Selective cyclooxygenase-2 inhibitor patch |
| 01/27/2005 | US20050020633 Nitroxide radioprotector formulations and methods of use |
| 01/27/2005 | US20050020615 Mixture of rapamycin with tertiary butanol or ethanol; anticancer agents, multiple sclerosis, rheumatic disease |
| 01/27/2005 | US20050020614 Stabilization plaque in blood vessels; therapy for restenosis in diabetic patients |
| 01/27/2005 | US20050020613 Analgesics; time-released; controlling dosage |
| 01/27/2005 | US20050020610 Mixture of disaccharides, polysaccharides and solvent |
| 01/27/2005 | US20050020571 Antiserotonine agents; psycholgical disorders; headaches |
| 01/27/2005 | US20050020569 Composition and method for treating erectile dysfunction and reducing fibrosis in erectile tissue of the human penis |
| 01/27/2005 | US20050020554 Encasing estrogen in oxygen impervious container ; purging with inert gas; contraceptives; hormone replacement therapy |
| 01/27/2005 | US20050020552 Pharmaceutical composition and method for transdermal drug delivery |
| 01/27/2005 | US20050020549 aqueous suspension; rhinitis therapy |
| 01/27/2005 | US20050020546 Pharmaceutical compositions comprising active vitamin D compounds |
| 01/27/2005 | US20050020539 Pharmaceutical compositions for the oral administration of heparin or derivatives thereof |
| 01/27/2005 | US20050020522 Induce mitrosis and smooth muscle proliferation; administering to cell or tissue a polynucleotide which codes endothelial growth factor |
| 01/27/2005 | US20050020509 Process for preparing tannate liquid and semi-solid dosage forms |
| 01/27/2005 | US20050020507 mixing acidic dextrose concentrate and buffer to form a ready-to-use solution; enhanced biocompatibility |
| 01/27/2005 | US20050020498 Apo-2 ligand/trail formulations |
| 01/27/2005 | US20050020489 Use of hcg and lh in controlled ovarian hyperstimulation |
| 01/27/2005 | US20050020199 Coin guiding apparatus |
| 01/27/2005 | US20050019926 Compositions of nucleic acids and cationic aminoglycosides and methods of using and preparing the same |
| 01/27/2005 | US20050019919 Infusion system for creating micro-environments in a living body |
| 01/27/2005 | US20050019884 Immobilization of oligonucleotides and proteins in sugar-containing hydrogels |
| 01/27/2005 | US20050019755 Formation of superparamagnetic particles |
| 01/27/2005 | US20050019436 Relieving pain at a body site by administering a dosage of capsaicinoid at the painful site without eliciting an effect outside the discrete location; local anesthetic effect; targeted therapy |
| 01/27/2005 | US20050019417 stabilization of proteins, peptides or cells by fluidization of microparticles to form fluidized bed of microparticles comprising water soluble gel forming solid particles, then spraying coating with liquids comprising sugars and solvents, and drying |
| 01/27/2005 | US20050019416 Encapsulated agglomeration of microcapsules and method for the preparation thereof |
| 01/27/2005 | US20050019414 Low temperature interconnection of nanoparticles |
| 01/27/2005 | US20050019413 Composition of matter comprising particles which contain choline chloride to be administered in a rumen protected and post-ruminally effective form |
| 01/27/2005 | US20050019412 comprising nanoparticles of antidiabetic agents and surfactants |
| 01/27/2005 | US20050019411 Powder for nasal administration of drugs |
| 01/27/2005 | US20050019410 dissolving particles in solvents and then precipitation by mixing the solutions with nonsolvents and spray drying to form microstructure particles; imaging contrast enhancing agents used for medical diagnosis |
| 01/27/2005 | US20050019409 Gastric retention dosage form having multiple layers |
| 01/27/2005 | US20050019408 time-release agents comprising water-swellable matrix cores containing estrogen derivative extracted from animals surrounded by film-forming coatings |
| 01/27/2005 | US20050019407 Composite dosage forms |
| 01/27/2005 | US20050019406 Mixing ribavirin with excipient; pelletization; coating with material that reduces dissolution rate in water; sustained release, free-flowing |
| 01/27/2005 | US20050019405 Controlled release composition |
| 01/27/2005 | US20050019404 Drug-eluting biodegradable stent |
| 01/27/2005 | US20050019403 comprising immediate release, sustained release and delayed release dosage forms, with each dosage forms having a different release profile, wherein each reaches a maximum concentration at different times |
| 01/27/2005 | US20050019402 Antibiotic product, use and formulation thereof |
| 01/27/2005 | US20050019401 comprising immediate release, sustained release and delayed release dosage forms, with each dosage forms having a different release profile, wherein each reaches a maximum concentration at different times |
| 01/27/2005 | US20050019400 Controlled-release drug delivery system |
| 01/27/2005 | US20050019399 Oral administering; mixture of amorphous drug and polymer; carvedilol |
| 01/27/2005 | US20050019398 Flashmelt oral dosage formulation |
| 01/27/2005 | US20050019397 Cellulosic fiber containing composition |
| 01/27/2005 | US20050019396 formed by mixing metal salts with the aqueous solutions, then mixing with bases to increase the pH of the aqueous solution and forming suspensions of antibiotic metal complex, and drying the suspension by dry granulation |
| 01/27/2005 | US20050019395 Formulations of amlodipine maleate |
| 01/27/2005 | US20050019393 comprising highly-compactable fillers, highly water-absorbing material and water and drugs loaded onto particles; sustained release |
| 01/27/2005 | US20050019392 Pharmaceutical composition as solid dosage form and method for manufacturing thereof |
| 01/27/2005 | US20050019391 Orodispersible tablet having high homogeneity and the preparation method thereof |
| 01/27/2005 | US20050019390 Dosage system and dosage vehicle therefor |
| 01/27/2005 | US20050019389 Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
| 01/27/2005 | US20050019388 Polyglutamic acid and/or salt that may be crosslinked with a calcium, iron, aluminum, and/or chromium compound; drugs, foods; acid resistant, made of non-animal materials |
| 01/27/2005 | US20050019387 Therapeutically effective amount of liposomal entrapped irinotecan also comprising cardiolipin, and a pharmaceutically acceptable exipient, wherein at least a portion of irinotecan is complexed with cardiolipin; use in treating proliferative diseases such as cancer |
| 01/27/2005 | US20050019386 In mixture of membrane-forming amphiphiles subjected to high pressure homogenization or ultrasound; contain immunomodulator, cyclosporin, and/or at least one cytokine or polyethylene glycol-cytokines |
| 01/27/2005 | US20050019385 Composition and method for controlling drug delivery from silicone adhesive blends |
| 01/27/2005 | US20050019384 Mixture for transdermal delivery of low and high molecular weight compounds |
| 01/27/2005 | US20050019383 Adhesive surface with indentations; second component being separated by a cup shaped metal foil barrier layer with a rim extending into a flange; wound healing agents; topical |
| 01/27/2005 | US20050019382 Continuous production of solvent-free and mastication-free pressure senstive adhesive styrene block copolymer (SBC); supplying, compounding, homogenizing |
| 01/27/2005 | US20050019381 Binding agent which is stable in storage and used for pharmaceutical applications |
| 01/27/2005 | US20050019378 Transdermal drug delivery system of strychnine, brucine, securinine and their salts |
| 01/27/2005 | US20050019377 Dietary fiber delivery system |
| 01/27/2005 | US20050019376 Containing at least one active ingredient and a confectionery composition such as fat, amorphous sugar glass, or fondant; polarized light transmission; especially for pediatric and geriatric applications |
| 01/27/2005 | US20050019374 Plasticizer, film former, bulking agent, and pH controlling agent; |
| 01/27/2005 | US20050019373 Nucleic acid antioxidant compositions, methods for obtaining such compositions and formulations thereof |
| 01/27/2005 | US20050019371 Controlled release bioactive agent delivery device |
| 01/27/2005 | US20050019370 Drug delivery device containing viable cells implanted into blood vessel; cells produce and secrete the pre-selected molecule into systemic circulation; capsule held in place by anchored blood permeable element |
| 01/27/2005 | US20050019369 making a suture by modifying an aqueous suspension of a nucleic acid, e.g., by capping, crosslinking, methylation, ethylation, or attachment of a protein, to form a viscous gel, which is extruded to form a filament; optionally adding a biodegradable polymer |
| 01/27/2005 | US20050019367 Continuous release of luteinizing hormone releasing hormone (lh-rh) analogue of leuprorelin, buserelin, triptorelin, and/or goserelin |
| 01/27/2005 | US20050019352 Method for preparing a water/oil/water multiple emulsion |
| 01/27/2005 | US20050019350 Gel emulsions in the form of o/w emulsions having a hydrocolloid content |
| 01/27/2005 | US20050019349 Poxvirus containing formulations and process for preparing stable poxvirus containing compositions |
| 01/27/2005 | US20050019343 administering an effective dose of a polypeptide comprising an immunogenic fragment of A beta (SEQ ID NO:1) and an adjuvant in a regime effective to induce an immune response comprising antibodies to the A beta fragment; Alzheimer's disease |
| 01/27/2005 | US20050019339 Forming antibodies that recognize epitopes in nature protein; antigen encapsulated in liposomes |
| 01/27/2005 | US20050019330 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta |
| 01/27/2005 | US20050019303 Biodegradable copolymer, and polymeric micelle composition containing the same |
| 01/27/2005 | US20050019295 Homogeneous, thermoreversible low viscosity polymannan gum films and soft capsules made therefrom |
| 01/27/2005 | US20050019294 Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| 01/27/2005 | US20050019274 Biofilm removing agent for removing a biofilm |
| 01/27/2005 | US20050019273 Thin flakes in hydratable matrix |
| 01/27/2005 | US20050019272 Divided container containing cleaning compound; sealable opening; aqueous solution og hydrgen peroxide |
| 01/27/2005 | US20050019271 Glycopyrrolate in sustained releae form; antimuscarinic agents |
| 01/27/2005 | US20050019270 Formulation of powder containing nanoparticles for aerosol delivery to the lungs |
| 01/27/2005 | US20050019268 Spray containing ubiquinone Qn |
| 01/27/2005 | US20050019266 Therapeutic ultrasond; imaging vascular plaque; administering contrast agent in aqueous carrier; scanning |
| 01/27/2005 | US20050016391 Dietary fiber delivery system |
| 01/27/2005 | DE10331350A1 Inhalation powder useful for treating respiratory diseases comprises a 9,9-dimethyl-7-(2,2-diphenylpropionyloxy)-3-oxa-9-azatricyclononane salt and a finely divided excipient |
| 01/27/2005 | DE10328942A1 Transmukosale Darreichungsformen mit verminderter Schleimhautirritation Transmucosal dosage forms with reduced mucosal irritation |
| 01/27/2005 | CA2573060A1 Asymmetric disulfides and methods of using same |
| 01/27/2005 | CA2533314A1 Prevention of molecular weight reduction of the polymer, impurity formation and gelling in polymer compositions |
| 01/27/2005 | CA2533165A1 Gellan gum based oral controlled release dosage forms- a novel platform technology for gastric retention |
| 01/27/2005 | CA2533084A1 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 01/27/2005 | CA2532485A1 Tablets containing ambroxol |